
Eczema
Latest News
Latest Videos

Shorts

CME Content
More News

Almirall initiates a pivotal phase 3 trial for lebrikizumab, targeting nummular eczema and aiming to enhance treatment options for this challenging condition.

A phase 2 extension trial found roflumilast foam safe and effective for up to 52 weeks in patients with moderate to severe seborrheic dermatitis.

In the latest Cutaneous Connection podcast episode, Renata Block, DMSc, MMS, PA-C, and Isabelle Thibau, MPH, discuss the National Eczema Association's EczemaWise app and how it can be used by both clinicians and patients.

Cases of dermatitis in workers and consumers alike show how allergen exposure transcends occupational boundaries.

Discover how the NEA Seal of Acceptance helps clinicians recommend safe eczema products, ensuring quality and sensitivity for patients with atopic dermatitis.

Jacob Thyssen, PhD, discusses tralokinumab's promising results for hand eczema, highlighting its potential to transform treatment options for patients.

Elderly patients show lower and more mild patch test reactivity than younger individuals, with different sensitization patterns.

New insights reveal shared and allergen-specific immune responses in allergic contact dermatitis.

The NEA’s Sam Iannotti, MPH, discusses how the Seal of Acceptance helps patients and clinicians identify products that meet rigorous eczema care standards.

The company also announced in a press release that the product received the Seal of Acceptance by the NEA.

Researchers conducted a comprehensive review of ACD, detailing the condition’s epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.

In the first Derm Dispatch episode, Renata Block, MMS, PA-C, and Peter Lio, MD, discuss integrative approaches to managing eczema, including the use of holistic treatments.

According to a survey, both patients and clinicians are unsatisfied with the current therapeutic landscape and are looking for options that better fulfill patient needs.

A Finnish review highlights imprecise use of L23.8 and L23.9 codes for allergic contact dermatitis.

While zinc deficiency shows strong ties to SD, researchers stated vitamin D's role is less clear and may depend on genetic factors.

Belleson addresses one of the NEA's Eczema Awareness Month weekly themes, “The eczema community is here to inspire you.”

Shi addresses one of the NEA's Eczema Awareness Month weekly themes, "Creative ways to manage your eczema."

Lio addresses one of the NEA's Eczema Awareness Month weekly themes, "What is eczema?"













